ICDs (implantable cardioverter defibrillators) should be used cautiously for HCM (hypertrophic cardiomyopathy), says study
This article was originally published in Clinica
Executive Summary
More research is needed to develop ways of identifying which patients with hypertrophic cardiomyopathy (HCM), a genetic disorder of the heart muscle, are likely to benefit from the implantation of a cardioverter defibrillator (ICD), according to a UK study.